Changes

Jump to: navigation, search

Timeline of vaccines

678 bytes added, 18:48, 2 June 2020
no edit summary
|-
| 2012 || || || Vaccine approval || A quadrivalent inactivated influenza vaccine is licensed in the {{w|United States}}.<ref>{{cite web|title=Influenza|url=https://www.historyofvaccines.org/content/articles/influenza|website=historyofvaccines.org|accessdate=26 April 2018}}</ref> ||
|-
| 2012 || December 12 || || || "On December 11, 2012, the Institute for Safe Medication Practices (ISMP) issued a press release announcing the launch of its new Vaccine Error Reporting Program. The program allows healthcare professionals to confidentially report vaccine administration errors and near misses. According to the press release, the program's goal is to better quantify sources of errors and advocate for product changes (such as changes to the vaccine name or label) that will ensure patient safety."<ref>{{cite web |title=Issue 1033: January 2, 2013 |url=https://www.immunize.org/express/issue1033.asp |website=immunize.org |accessdate=3 June 2020}}</ref> ||
|-
| 2013 || January 25 || {{w|Pneumococcal disease}} || Vaccine approval || "FDA approved use of Prevnar 13 vaccine in older children and teens (6-17 years)."<ref>{{cite web |title=PFIZER RECEIVES FDA APPROVAL FOR THE USE OF PREVNAR 13 IN VACCINE-NAIVE CHILDREN AND ADOLESCENTS AGED 6 YEARS THROUGH 17 YEARS FOR THE PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE |url=https://www.pfizer.com/news/press-release/press-release-detail/pfizer_receives_fda_approval_for_the_use_of_prevnar_13_in_vaccine_naive_children_and_adolescents_aged_6_years_through_17_years_for_the_prevention_of_invasive_pneumococcal_disease |website=pfizer.com |accessdate=3 June 2020}}</ref> ||
62,446
edits

Navigation menu